Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Mar 14;23(10):1735-1746.
doi: 10.3748/wjg.v23.i10.1735.

Portal hypertension: Imaging of portosystemic collateral pathways and associated image-guided therapy

Affiliations
Review

Portal hypertension: Imaging of portosystemic collateral pathways and associated image-guided therapy

Murad Feroz Bandali et al. World J Gastroenterol. .

Abstract

Portal hypertension is a common clinical syndrome, defined by a pathologic increase in the portal venous pressure. Increased resistance to portal blood flow, the primary factor in the pathophysiology of portal hypertension, is in part due to morphological changes occurring in chronic liver diseases. This results in rerouting of blood flow away from the liver through collateral pathways to low-pressure systemic veins. Through a variety of computed tomographic, sonographic, magnetic resonance imaging and angiographic examples, this article discusses the appearances and prevalence of both common and less common portosystemic collateral channels in the thorax and abdomen. A brief overview of established interventional radiologic techniques for treatment of portal hypertension will also be provided. Awareness of the various imaging manifestations of portal hypertension can be helpful for assessing overall prognosis and planning proper management.

Keywords: Diagnostic imaging; Image-guided therapy; Portal hypertension; Portosystemic collaterals.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: Authors declare no potential conflicts of interests. No financial support.

Figures

Figure 1
Figure 1
Normal portal venous anatomy and direction of blood flow. The main portal vein (MPV) is most commonly formed when the splenic vein (SV) and the superior mesenteric vein (SMV) join. While variable, the inferior mesenteric vein (IMV) most commonly drains in to the splenic vein, at the level of the pancreatic body. Other tributaries may also join the MPV, such as the left gastric vein (LGV) as depicted here.
Figure 2
Figure 2
Portosystemic collateral pathways and direction of blood flow in portal hypertension. Progressive resistance to hepatopetal flow results in slowed and eventually reversed flow in the main portal vein (MPV). Portal venous system decompresses by recruiting several pre-exiting collateral pathways, the selection of which is partly dictated by the location of the portal venous resistance. Paraumbilical (PUVar), abdominal wall varices (AWVar), esophageal (EVar), paraesophageal (PEVar), gastric (GVar), cardiophrenic (CPVar), mesenteric (MVar) and rectal (RVar) varices may be created in order to allow the passage the portal venous blood into systemic circulation. LGV: Left gastric vein; SV: Splenic vein; IMV: Inferior mesenteric vein; IVC: Inferior vena cava; SRS: Splenorenal shunt; GRS: Gastrorenal shunt.
Figure 3
Figure 3
Axial enhanced computed tomography of the upper abdomen in portal venous phase demonstrates multiple large tubular and serpiginous esophageal (white arrow) and paraesophageal (black arrow) varices at the level of the esophageal hiatus of the diaphragm.
Figure 4
Figure 4
Endoscopic image of large tortuous submucosal esophageal varices protruding into the esophageal lumen.
Figure 5
Figure 5
Axial (A) and coronal (B) cross-sectional enhanced computed tomography images show large paraesophageal varices (white arrow) surrounding the esophagus circumferentially in a patient with liver cirrhosis and portal hypertension. Note the nodular and shrunken liver, low-density abdominal ascites and splenomegaly.
Figure 6
Figure 6
Coronal post-gadolinium T1-weighted fat-suppressed magnetic resonance image shows prominent cardiophrenic (white arrow) and pericardial collateral veins (dashed white arrow) in a patient with Budd-Chiari syndrome.
Figure 7
Figure 7
Enhanced axial computed tomography image acquired in portal venous phase demonstrates large upper abdominal omental varices (white arrow). Additionally, several enlarged submucosal gastric (black arrow) and short gastric varices (dashed black arrow).
Figure 8
Figure 8
Retroflexed endoscopic image of large tortuous submucosal gastric varices (black star).
Figure 9
Figure 9
Coronal enhanced computed tomography image demonstrates a large gastrorenal shunt (black arrow) and perigastric, as well as, gastric submucosal varices (white arrow) in a patient with liver cirrhosis and portal hypertension.
Figure 10
Figure 10
Axial enhanced computed tomography acquired in portal venous phase demonstrates a prominent splenorenal shunt (A, white arrow), left anterior oblique three dimensional computed tomography reconstruction re-demonstrates spontaneous splenorenal shunt draining portal venous blood into the left extra-hilar main renal vein (B). MPV: Main portal vein; SMV: Superior mesenteric vein; IVC: Inferior vena cava; SV: Splenic vein; SRS: Spontaneous splenorenal shunt; MRV: Main renal vein.
Figure 11
Figure 11
Sagittal (A) and transverse midline (B) Doppler sonographic images demonstrate turbulent flow within a recanalized paraumbilical vein.
Figure 12
Figure 12
Axial enhanced computed tomography image acquired in portal venous phase (A) and coronal-oblique three-dimensional computed tomography reconstruction (B) demonstrating large paraumbilical varices with large associated caput medusa.
Figure 13
Figure 13
Right anterior oblique three-dimensional computed tomography reconstruction shows mesocaval collateral veins shunting blood from the inferior mesenteric vein to the inferior vena cava via the right ovarian vein.
Figure 14
Figure 14
Transjugular intrahepatic portosystemic shunt procedure performed on a 54-year-old male with alcohol-induced cirrhosis and portal hypertension who presents with intractable ascites. A: Rosch-Uchida transjugular intrahepatic portosystemic shunt (TIPS) trochar-needle set (Cook Medical, Bloomington, United States) was advanced into an anterior branch of the right portal vein successfully after four attempts; B: Subsequently a wire and pigtail catheter were advanced into the main portal vein and subtraction angiography was performed demonstrating large dilated left gastric varices; C: Viatorr polytetrafluoroethylene (PTFE)-covered self-expanding stent (Gore Medical, Flagstaff, United States) was deployed over the tract; D: Completion portography demonstrates patency of the TIPS with decreased overall flow into the gastric varices.
Figure 15
Figure 15
Retrograde balloon occlusion of gastro-renal shunt via femoral venous approach coursing through the inferior vena cava and left renal vein. After balloon occlusion, a sclerosing agent is injected into the gastric varices (GVar). Black arrows indicate directional blood flow. MPV: Main portal vein; IMV: Inferior mesenteric vein; IVC: Inferior vena cava; GRS: Gastrorenal shunt.
Figure 16
Figure 16
Coil-assisted retrograde transvenous obliteration of gastric varices in a 55-year-old patient who presented with recurrent gastric variceal bleeding refractory to endoscopic therapy. A: Angled catheter was navigated into the left gastrorenal shunt after obtaining access from the right common femoral vein and advancing 5-french sheath into the inferior vena cava; B: Digital subtraction angiography performed through the gastrorenal shunt demonstrating large dilated shunt vessels, as well as, secondary outflow through pericardiophrenic collaterals; C: Both the proximal and distal shunts were coil-occluded and gelfoam was utilized to embolize and thrombose the gastric varices.

Similar articles

Cited by

References

    1. Bosch J, Groszmann RJ, Shah VH. Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. J Hepatol. 2015;62:S121–S130. - PMC - PubMed
    1. Bosch J, Abraldes JG, Fernández M, García-Pagán JC. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J Hepatol. 2010;53:558–567. - PubMed
    1. Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, Morard I, Lasser L, Langlet P, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology. 2010;51:210–218. - PubMed
    1. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838–851. - PMC - PubMed
    1. Bosch J, Navasa M, Garcia-Pagán JC, DeLacy AM, Rodés J. Portal hypertension. Med Clin North Am. 1989;73:931–953. - PubMed

MeSH terms